Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2M Sell
183,080
-919,320
-83% -$108M 0.65% 32
2025
Q4
$138M Buy
1,102,400
+167,105
+18% +$19.9M 3.57% 11
2025
Q3
$112M Buy
+935,295
New +$98.8M 3.04% 11
2025
Q2
Sell
-1,083,065
Closed -$95.3M 71
2025
Q1
$95.3M Sell
1,083,065
-164,600
-13% -$16.2M 4.46% 6
2024
Q4
$115M Buy
1,247,665
+169,850
+16% +$16.3M 3.83% 6
2024
Q3
$100M Buy
1,077,815
+294,995
+38% +$24.8M 3.64% 8
2024
Q2
$58.7M Buy
782,820
+274,970
+54% +$21.9M 2.17% 21
2024
Q1
$43.8M Buy
+507,850
New +$38.8M 1.57% 24

Other funds holding CRH

Munro Partners's CRH Position: Q1 2026 in Review

Munro Partners reduced its CRH (CRH) stake by 83% in Q1 2026, selling an estimated $108M and leaving 183,080 shares worth $19.2M. The position accounts for 0.65% of the portfolio, ranked #32.

Munro Partners first reported a position in CRH in Q1 2024 and has held it in 8 quarters since. The position peaked at $138M in Q4 2025. 1,010 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Munro Partners held 183,080 shares of CRH worth $19.2M as of Q1 2026.
  • Munro Partners sold 919,320 CRH shares in Q1 2026, an estimated $108M.
  • CRH made up 0.65% of Munro Partners's portfolio in Q1 2026, its #32 holding.
  • Munro Partners first reported a position in CRH in Q1 2024 and has held it in 8 quarters since.
  • Munro Partners's CRH position peaked at $138M in Q4 2025.
  • 1,010 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Munro Partners's 13F filing for Q1 2026, filed 6 May 2026.